Document is current
Any future updates will be listed below
-
Authors
Jonmarker, Sandra http://orcid.org/0000-0001-5836-8594
Alarcón, Felix
Litorell, Jacob
Granholm, Anders
Alm, Eva Joelsson
Chew, Michelle
Russell, Lene
Weihe, Sarah
Madsen, Emilie Kabel
Meier, Nick
Leistner, Jens Wolfgang
Mårtensson, Johan
Hollenberg, Jacob
Perner, Anders
Kjær, Maj-Brit Nørregaard
Munch, Marie Warrer
Dahlberg, Martin
Cronhjort, Maria
Wahlin, Rebecka Rubenson
-
Funding
Funding for this research was provided by:
Novo Nordisk Fonden
Karolinska Institute
- License Information
-
More Information
Article History
Received: 15 November 2022
Accepted: 23 February 2023
First Online: 2 March 2023
Declarations
:
: DenmarkEthics committee number H-20051056.EudraCT number 2020-003363-25.Danish Medicines Agency number 2020-07-16.SwedenEthics committee number 2020-02582, 2020-04403.EudraCT number 2020-001395-15.<b><i>Ethics approval for local databases.</i></b>DenmarkEthics committee number 31-1521-293, R-21004283.SwedenEthics committee number 2022-00152-02.
: Not applicable.
: Anders Granholm, Lene Russell, Anders Perner, Maj-Brit Nørregaard Kjær, and Marie W. Munch are affiliated with the Department of Intensive Care at Rigshospitalet, University of Copenhagen, which has received grants from the Novo Nordisk Foundation during the conduct of the trial; and grants from Pfizer, Fresenius Kabi, The Novo Nordisk Foundation, and Sygeforsikringen “danmark” outside the submitted work, and conduct contract research for AM-Pharma. No other disclosures were reported.
